Raymond Neil T, Varadhan Lakshminarayanan, Reynold Dilini R, Bush Kate, Sankaranarayanan Sailesh, Bellary Srikanth, Barnett Anthony H, Kumar Sudhesh, O'Hare J Paul
Health Sciences Research Institute, Warwick Medical School, University of Warwick, Coventry, UK.
Diabetes Care. 2009 Mar;32(3):410-5. doi: 10.2337/dc08-1422. Epub 2008 Dec 15.
The purpose of this study was to compare prevalence and risk factors for diabetic retinopathy among U.K. residents of South Asian or white European ethnicity.
This was a community-based cross-sectional study involving 10 general practices; 1,035 patients with type 2 diabetes were studied: 421 of South Asian and 614 of white European ethnicity. Diabetic retinopathy, sight-threatening retinopathy, maculopathy, and previous laser photocoagulation therapy were assessed after grading of retinal photographs. Data were collected on risk factors including age, duration, and treatment of diabetes, blood pressures, serum total cholesterol, and A1C.
Patients of South Asian ethnicity had significantly higher systolic (144 vs. 137 mmHg, P < 0.0001) and diastolic (84 vs. 74 mmHg, P < 0.0001) blood pressure, A1C (7.9 vs. 7.5%, P < 0.0001), and total cholesterol (4.5 vs. 4.2 mmol/l, P < 0.0001). Diabetic retinopathy was detected in 414 (40%) patients (189 South Asian [45%] versus 225 white European [37%]; P = 0.0078). Sight-threatening retinopathy was detected in 142 (14%) patients (68 South Asian [16%] versus 74 white European [12%]; P = 0.0597). After adjustment for confounders, there were significantly elevated risks of any retinopathy and maculopathy for South Asian versus white European patients.
Patients of South Asian ethnicity had a significantly higher prevalence of diabetic retinopathy and maculopathy, with significantly elevated systolic and diastolic blood pressure, A1C, and total cholesterol; lower attained age; and younger age at diagnosis. Earlier onset of disease and higher levels of modifiable risk factors make early detection of diabetes, annual referral for retinal screening, and intensive risk factor control key elements in addressing this health inequality.
本研究旨在比较英国南亚裔和白人欧洲裔居民糖尿病视网膜病变的患病率及危险因素。
这是一项基于社区的横断面研究,涉及10家普通诊所;对1035例2型糖尿病患者进行了研究,其中南亚裔421例,白人欧洲裔614例。在对视网膜照片进行分级后,评估糖尿病视网膜病变、威胁视力的视网膜病变、黄斑病变以及既往激光光凝治疗情况。收集了包括年龄、糖尿病病程及治疗情况、血压、血清总胆固醇和糖化血红蛋白(A1C)等危险因素的数据。
南亚裔患者的收缩压(144 vs. 137 mmHg,P < 0.0001)和舒张压(84 vs. 74 mmHg,P < 0.0001)、A1C(7.9 vs. 7.5%,P < 0.0001)以及总胆固醇(4.5 vs. 4.2 mmol/l,P < 0.0001)显著更高。414例(40%)患者检测出糖尿病视网膜病变(南亚裔189例[45%],白人欧洲裔225例[37%];P = 0.0078)。142例(14%)患者检测出威胁视力的视网膜病变(南亚裔68例[16%],白人欧洲裔74例[12%];P = 0.0597)。在对混杂因素进行调整后,南亚裔患者发生任何视网膜病变和黄斑病变的风险显著高于白人欧洲裔患者。
南亚裔患者糖尿病视网膜病变和黄斑病变的患病率显著更高,收缩压和舒张压、A1C及总胆固醇水平显著升高;达到的年龄更低,诊断时年龄更小。疾病的早发和可改变危险因素的较高水平使得早期发现糖尿病、每年转诊进行视网膜筛查以及强化危险因素控制成为解决这一健康不平等问题的关键要素。